Fundraising FoxProcarta Biosystems
2 known investors
Find your way into Procarta Biosystems
Sign up to see every warm intro you have to Procarta Biosystems
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Procarta Biosystems team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Procarta Biosystems develops gene control technology to treat drug-resistant bacterial infections, including MRSA. The company was spun out from the John Innes Centre and Plant Biosciences Limited and focuses on anti-infective therapeutics for the biotech and pharmaceutical sector.
Founders & leadership
PM
Prof. Mervyn Bibb
Board
DS
Dr. Sam PitersonChairman
Investors · 2
Morningside Group✓ confirmed by Procarta BiosystemsHong Kong
How we know: the company's own site · Not right? Tell us
Future Planet Capitallisted by Future Planet CapitalLondon
How we know: Future Planet Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Procarta Biosystems do?
- Procarta Biosystems develops gene control technology to treat drug-resistant bacterial infections, including MRSA. The company was spun out from the John Innes Centre and Plant Biosciences Limited and focuses on anti-infective therapeutics for the biotech and pharmaceutical sector.
- Who founded Procarta Biosystems?
- Procarta Biosystems was founded by Prof. Mervyn Bibb.
- Who are Procarta Biosystems's investors?
- Procarta Biosystems's investors include Morningside Group, Future Planet Capital.